miR-145-5phsa-let-7a-3p:

Nazila Mozammel1, Elham Baghbani2, Mohammad Amini2

  • 1Department of Biology, Higher Education Institute of Rab-Rashid, Tabriz, Iran.

概括

替换瘤抑制器微RNA let-7和MIR-145一起显著降低了结直肠癌细胞的增殖和增加了亡. 这种联合miRNA疗法显示出作为结直肠癌 (CRC) 新治疗策略的前景.